By Brian Mihalik and John MacDougallThe US Food and Drug Administration (FDA) has taken action to crack down on the growing number of Chinese manufacturers of illegal drugs in a series of actions against the country’s most prolific and notorious drug makers.
According to a press release issued on Friday, FDA has seized a total of $11 billion in Chinese drugs since it began tracking drug shipments in 2016.
The US agency is also taking action against companies and entities that manufacture, distribute, or import Chinese-made products to the US.
These actions are the result of an ongoing FDA investigation into the export of a broad range of counterfeit and pirated drugs that are being shipped into the United States.
These include:A drug, anabolic steroids, that is manufactured and sold in China using a Chinese-designed process that bypasses the FDA and the International Traffic in Arms Regulations (ITAR) and uses an unapproved biopesticide (also known as a synthetic form of herbicide) to boost the body’s ability to manufacture anabolic hormones.
The drugs were purchased from the Chinese company Cebi International Group.
This is the second time that the FDA has taken these actions against Cebis.
In September, the agency also issued a $1.5 million fine against Cibib, a Chinese pharmaceutical firm that has been accused of illegally exporting more than 10 million pounds of counterfeit medicines to the United Kingdom.